- Home
- CBNK vs NKTR Comparison
CBNK vs NKTR Comparison
Compare CBNK & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBNK
- NKTR
- Stock Information
- Founded
- CBNK 1974
- NKTR 1990
- Country
- CBNK United States
- NKTR United States
- Employees
- CBNK N/A
- NKTR N/A
- Industry
- CBNK Major Banks
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- CBNK Finance
- NKTR Health Care
- Exchange
- CBNK Nasdaq
- NKTR Nasdaq
- Market Cap
- CBNK 563.7M
- NKTR 558.0M
- IPO Year
- CBNK 2018
- NKTR 1994
- Fundamental
- Price
- CBNK $34.08
- NKTR $40.18
- Analyst Decision
- CBNK Hold
- NKTR Strong Buy
- Analyst Count
- CBNK 1
- NKTR 6
- Target Price
- CBNK $35.00
- NKTR $81.67
- AVG Volume (30 Days)
- CBNK 57.4K
- NKTR 884.5K
- Earning Date
- CBNK 10-27-2025
- NKTR 11-06-2025
- Dividend Yield
- CBNK 1.41%
- NKTR N/A
- EPS Growth
- CBNK 11.33
- NKTR N/A
- EPS
- CBNK 2.69
- NKTR N/A
- Revenue
- CBNK $205,155,000.00
- NKTR $74,934,000.00
- Revenue This Year
- CBNK $47.22
- NKTR N/A
- Revenue Next Year
- CBNK $7.72
- NKTR N/A
- P/E Ratio
- CBNK $12.69
- NKTR N/A
- Revenue Growth
- CBNK 30.26
- NKTR N/A
- 52 Week Low
- CBNK $24.10
- NKTR $6.48
- 52 Week High
- CBNK $36.40
- NKTR $40.45
- Technical
- Relative Strength Index (RSI)
- CBNK 55.29
- NKTR 82.74
- Support Level
- CBNK $33.50
- NKTR $27.87
- Resistance Level
- CBNK $34.61
- NKTR $30.45
- Average True Range (ATR)
- CBNK 0.86
- NKTR 2.10
- MACD
- CBNK 0.13
- NKTR 0.96
- Stochastic Oscillator
- CBNK 73.10
- NKTR 98.21
About CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.